BIOMAT Database Logo BIOMAT Database Logo

Prevalence and therapeutic significance of anti-interferon antibodies in hepatitis C virus/HIV-co-infected patients. 2007

Belen Ramos, and Julie Sheldon, and Andres Ruiz-Sancho, and Carlos Toro, and Pilar Ríos, and Vincent Soriano

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011092 Polyethylene Glycols Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS. Macrogols,Polyoxyethylenes,Carbowax,Macrogol,Polyethylene Glycol,Polyethylene Oxide,Polyethyleneoxide,Polyglycol,Glycol, Polyethylene,Glycols, Polyethylene,Oxide, Polyethylene,Oxides, Polyethylene,Polyethylene Oxides,Polyethyleneoxides,Polyglycols,Polyoxyethylene
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077190 Interferon alpha-2 Alpha interferon encoded by the human IFNA2 gene. Recombinant forms are used in the treatment of CHRONIC HEPATITIS B; CHRONIC HEPATITIS C; KAPOSI SARCOMA; MELANOMA; and HAIRY CELL LEUKEMIA. IFN-alpha 2,IFN-alpha-2,IFNalpha-2b, Recombinant,Interferon alfa-2a,Interferon alfa-2b,Interferon alpha-2b, Recombinant,Interferon alpha-A,Interferon-alpha 2,Intron A (Interferon),LeIF A,Reaferon,Recombinant Interferon alpha-2a,Recombinant Interferon alpha-2b,Ro 22-8181,Roferon-A,Sch-30500,Viferon,IFNalpha 2b, Recombinant,Interferon alfa 2a,Interferon alfa 2b,Interferon alpha 2,Interferon alpha 2b, Recombinant,Interferon alpha A,Interferon alpha-2a, Recombinant,Recombinant IFNalpha-2b,Recombinant Interferon alpha 2a,Recombinant Interferon alpha 2b,Ro 22 8181,Ro 228181,Roferon A,RoferonA,Sch 30500,Sch30500
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral

Related Publications

Belen Ramos, and Julie Sheldon, and Andres Ruiz-Sancho, and Carlos Toro, and Pilar Ríos, and Vincent Soriano
Loss of anti-hepatitis C virus antibodies following therapeutic sustained virological response in a HIV co-infected patient.
June 2014, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy,
Belen Ramos, and Julie Sheldon, and Andres Ruiz-Sancho, and Carlos Toro, and Pilar Ríos, and Vincent Soriano
[Hepatitis C virus antibodies. Seroprevalence in HIV infected patients].
September 1992, Presse medicale (Paris, France : 1983),
Belen Ramos, and Julie Sheldon, and Andres Ruiz-Sancho, and Carlos Toro, and Pilar Ríos, and Vincent Soriano
Prevalence of hepatitis C virus among HIV-infected patients.
April 2020, Iranian journal of microbiology,
Belen Ramos, and Julie Sheldon, and Andres Ruiz-Sancho, and Carlos Toro, and Pilar Ríos, and Vincent Soriano
Prevalence of anti-HCV antibodies among family contacts of hepatitis C virus-infected patients.
January 2002, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology,
Belen Ramos, and Julie Sheldon, and Andres Ruiz-Sancho, and Carlos Toro, and Pilar Ríos, and Vincent Soriano
Occult hepatitis B virus infection in HIV/hepatitis C virus co-infected patients.
July 2003, AIDS (London, England),
Belen Ramos, and Julie Sheldon, and Andres Ruiz-Sancho, and Carlos Toro, and Pilar Ríos, and Vincent Soriano
Prevalence of risk factors for hepatitis C virus in HIV-infected and HIV/hepatitis C virus-coinfected patients.
June 2007, Sexually transmitted diseases,
Belen Ramos, and Julie Sheldon, and Andres Ruiz-Sancho, and Carlos Toro, and Pilar Ríos, and Vincent Soriano
Antiretroviral activity of pegylated interferon alfa-2a in patients co-infected with HIV/hepatitis C virus.
March 2007, The Journal of antimicrobial chemotherapy,
Belen Ramos, and Julie Sheldon, and Andres Ruiz-Sancho, and Carlos Toro, and Pilar Ríos, and Vincent Soriano
Hepatitis B virus surface antigen and anti-hepatitis C virus rapid tests underestimate hepatitis prevalence among HIV-infected patients.
October 2014, HIV medicine,
Belen Ramos, and Julie Sheldon, and Andres Ruiz-Sancho, and Carlos Toro, and Pilar Ríos, and Vincent Soriano
Liver transplantation for HIV/hepatitis C virus co-infected patients.
January 2014, Hepatology research : the official journal of the Japan Society of Hepatology,
Belen Ramos, and Julie Sheldon, and Andres Ruiz-Sancho, and Carlos Toro, and Pilar Ríos, and Vincent Soriano
High uptake of hepatitis C virus treatment in HIV/hepatitis C virus co-infected patients attending an integrated HIV/hepatitis C virus clinic.
October 2011, International journal of STD & AIDS,
Copied contents to your clipboard!